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Abstract: Leukocoria in infants is always a danger signal as retinoblastoma, a malignant retinal 
tumor, is responsible for half of the cases in this age group. More common signs should also 
be considered suspicious until proved otherwise, such as strabismus, the second most frequent 
sign of retinoblastoma. Less frequent manifestations are inﬂ ammatory conditions resistant to 
treatment, hypopyon, orbital cellulitis, hyphema or heterochromia. Other causal pathologies, 
including persistent hyperplastic primary vitreous (PHPV), Coats’ disease, ocular toxocariasis 
or retinopathy of prematurity, may also manifest the same warning signs and require special-
ized differential diagnosis. Members of the immediate family circle are most likely to notice 
the ﬁ rst signs, the general practitioner, pediatrician or general ophthalmologist the ﬁ rst to be 
consulted. On their attitude will depend the ﬁ nal outcome of this vision and life-threatening 
disease. Early diagnosis is vital.
Keywords: leukocoria, strabismus, retinoblastoma, Coats’ disease, persistent hyperplastic 
primary vitreous (PHPV)
Introduction
Retinoblastoma represents the greatest challenge in the ﬁ eld of ophthalmology. 
Affecting very young infants, in most cases perfectly healthy in all other respects, 
this highly malignant cancer of the retina threatens those individuals with the longest 
potential lifespan. Survivors may be severely handicapped by lesions of the posterior 
pole affecting central visual function.
These children can be cured, however, at low cost and with minimal suffering, 
provided that treatment is given in the early stages of disease. At later stages treatment 
is costly, burdensome, and with no certain outcome.
Retinoblastoma is fortunately a rare disease, but other intraocular lesions may mimic 
the initial signs or clinical features and are sometimes called “pseudo-retinoblastomas” 
(Dollfus and Auvert 1953).
Retinoblastoma does, however, represent 80% of primary ocular tumors in children 
under 15 years of age (Mahoney et al 1990) 17% of all neonatal cancers (Halperin 
2000) and 1% of all deaths due to cancer (Miller 1969). All ages considered, it is the 
third most frequent cancer of the eye and ocular adnexa (20%) and represents 3% of 
all pediatric cancers (Scat et al 1996). Thus the importance of keeping in mind the 
possibility of retinoblastoma when confronted with suspicious signs such as a white 
pupil or leukocoria (Figure1a), the most common ﬁ rst manifestation, strabismus or 
any other unexplained signs.
In this article, other conditions to take into consideration in the differential diagnosis 
of leukocoria or other signs associated with retinoblastoma will be reviewed.
Clinical Ophthalmology 2007:1(4)432
Balmer and Munier
First signs
The primary sign is leukocoria. The term leukocoria, also 
known as “amaurotic cat’s eye”, literally means “white 
pupil” from the greek “leucos” (white) and “korê” (pupil) 
and is created by the reﬂ ection of incident light off the retinal 
lesion within the pupillary area when the fundus is directly 
illuminated (Figures 1a and 1b). Leukocoria is the most 
frequent sign (60%) and is associated with retinoblastoma 
in almost half of all infants presenting with a white pupil 
(Howard and Ellsworth 1965b). A white pupil is most often 
initially noticed by close family members (Abramson et al 
2003) or on ﬂ ash photography, this often the primary reason 
for consultation. It is, however, a late manifestation, the 
vital prognosis still good (88% at 5 years) but that for globe 
salvage uncertain. A number of other conditions, however, 
may also present with leukocoria as a ﬁ rst sign. These 
include persistent hyperplastic primary vitreous (PHPV), 
Coats’ disease, ocular toxocariasis, retinopathy of prematu-
rity, retinal hamartomas (Bourneville’s tuberous sclerosis, 
von Recklinhausen’s disease), congenital falciform fold 
or organized vitreous hemorrhage (Howard and Ellsworth 
1965a; Shields, Shields et al 1991).
The second most frequent primary manifestation is stra-
bismus (20%), an affection thus not to be taken lightly and 
requiring immediate ophthalmological examination com-
prising full fundus examination with a dilated pupil, under 
anesthesia if necessary. Strabismus is usually secondary to 
macular involvement and an invaluable early sign carrying 
an excellent life prognosis and every chance of preserving 
the globe.
Finally, in 20% of cases the ﬁ rst manifestation is atypical, 
often inﬂ ammatory or hypertensive, and common to both 
retinoblastoma and certain pseudo-retinoblastomas. Atypical 
signs can cause major problems in diagnosis (Binder 1974; 
Balmer et al 1994; de Leon et al 2005) and include red eye, 
uveitis, hypopyon, hyphema, heterochromia, rubeosis, glau-
coma or phthisis bulbi, in particular as ultimate complications 
of unchecked disease. These are very late signs carrying a 
far more reserved vital and functional prognosis.
Differential diagnosis
Depending on the clarity of the media, ﬁ rst signs, stage of 
disease, frequency, the type and gravity of complications 
associated with spontaneous evolution, the approach to 
differential diagnosis will be made according to whether 
diagnosis is simple, difﬁ cult or concerns rare diseases.
Simple diagnosis
With clear media, diagnosis is generally simple and can be 
made at ﬁ rst glance, such as in most cases of retinoblastoma, 
choroidal or optic nerve coloboma, falciform retinal fold, 
myelinated ﬁ bers, “Morning Glory Syndrome”, cataract, 
congenital toxoplasmosis or retinal capillary hemangioma.
Asymmetrical pupillary reﬂ exes, even leukocoria, may 
be associated with common strabismus or anisometropia. 
With strabismus, the reﬂ ex may be darker in the ﬁ xating 
eye due to a greater pigmentation of the macular area 
(Brückner’s phenomenon) (Brückner 1962). Other, more 
serious conditions, are also easily identifiable when 
of typical presentation, in particular Coats’ disease, 
persistent hyperplastic primary vitreous (PHPV), astrocytic 
hamartoma (Bourneville’s tuberous sclerosis) or retinopathy 
or prematurity.
Diffi cult diagnosis
Diagnosis of retinoblastoma or pseudo-retinoblastoma is 
much more difﬁ cult with opaque media or with atypical 
features.
Figure 1 (a) Left leukocoria in a 1 year-old boy with unilateral retinoblastoma. (b) 
Exophytic retinoblastoma with total retinal detachment.
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Late stages of PHPV and Coats’ disease are the most 
common conditions to mimic retinoblastoma (Balmer et al 
1988; Shields, Parsons, et al 1991). In the absence of the 
classical clinical triad or with atypical retinal lesions, diagnosis 
of retinal astrocytic hamartoma may also be problematic.
Inﬂ ammatory conditions, in particular ocular toxocaria-
sis, can lead to complex clinical features requiring a whole 
battery of investigations, including serology, ultrasonogra-
phy, and neuro-diagnostic tools.
Severe vitreous hemorrhage following trauma may trans-
form into a massive retinal gliosis and even develop calciﬁ ca-
tions (Yanoff et al 1971). The history may be confused, the 
trauma unrecognized or prenatal or, conversely, be wrongly 
held responsible for the clinical situation. Primary or secondary 
retinal detachment may further complicate the assessment.
Rare diseases
Sheer rarity of a disease can make diagnosis more difﬁ cult, 
such as in medulloepithelioma, optic nerve glioma, familial 
exudative vitreoretinopathy, X-linked retinoschisis, Norrie’s 
disease, or incontinentia pigmenti.
Table 1 gives a classiﬁ cation by system and by frequency 
of diseases involved in the differential diagnosis of retino-
blastoma.
Genetics
Retinoblastoma (Augsburger et al 1995; Abramson et al 
1998; Balmer and Munier 2002a; Aerts et al 2006; Bornfeld 
et al 2006) is a malignant tumor of the retina resulting from 
a double oncogenic mutation between the beginning of the 
3rd month of gestation and 4 years of age in an immature 
retinal cell, most likely a multipotent retinoblast (Munier 
2002), precursor cone cell.
Onset of the disease may thus occur in utero (Maat-Kievit 
et al 1993) and up to 4 years of age, with a mean age of appear-
ance of ﬁ rst signs of 7 months for bilateral cases, 24 months 
in unilateral disease (Balmer and Munier 2002a).
Retinoblastoma may be non hereditary (60%) or heredi-
tary (40%), the hereditary form showing a classic autosomal 
dominance pattern with 90% penetration at birth.
The RB1 gene belongs to the group of anti-oncogenes, 
also called tumor-suppressor genes.
According to the literature, the mean frequency of reti-
noblastoma is one in 20,000 live births (Balmer and Munier 
2002b) with no sex, race or geographic predilection and 
no known exogenous risk factors apart from the age of the 
parents, in particular that of the father (DerKinderen et al 
1990; Matsunaga et al 1990).
Clinical presentation
The clinical presentation of retinoblastoma varies according 
to the type of growth of the tumor and duration, the degree 
of vascularization and presence of calciﬁ cations, vitreous 
seeding, retinal detachment or hemorrhage.
The initial tumoral cell divisions may occur in different 
internal retinal layers, a tumor developing on the surface of 
the retina and into the vitreous cavity being called an endo-
Table I Differential diagnosis in infantile leukocoria
1. Tumors
Retinoblastoma
Medulloepithelioma
Naevoxanthome juvenile
Glioneuroma
Leukemia
Choroidal hemangioma
Combined retinal hamartoma
2. Phakomatoses
Astrocytic hamartoma (Bourneville’s tuberous sclerosis)
Retinal capillary hemangioma (von Hippel-Lindau)
Encephalotrigeminal syndrome (Sturge-Weber)
Neurofi bromatosis (von Recklinhausen) (NF–1)
3. Congenital malformations
Persistent Hyperplastic Fetal Vasculature (PHFV)
Posterior coloboma
Retinal fold
Myelinated nerve fi bres
Morning Glory Syndrome
X-linked retinoschisis
Retinal dysplasia
Norrie’s disease
Incontinentia pigmenti
4. Vascular diseases
Retinopathy of prematurity
Coats’ disease
Familial exudative vitreoretinopathy
5. Infl ammatory diseases
Ocular toxocariasis
Congenital toxoplasmosis
Congenital cytomegalovirus retinitis
Herpes simplex retinitis
Other types of fetal iridochoroiditis
Pseudo-uveitis
Endophthalmitis
6. Trauma
Contusion of the globe
Intraocular foreign body
Shaken baby syndrome
7. Divers
Vitreous hemorrhage
Retinal detachment
Strabismus (Brückner’s phenomenon)
Stickler syndrome
Clinical Ophthalmology 2007:1(4)434
Balmer and Munier
phytic growth, while that developing from the external layers, 
invading the subretinal space and causing a retinal detachment 
an exophytic growth. A mixed growth involves the association 
of these two types. More rarely (2%), the tumor may develop 
in an insidious manner within the retinal layers and subretinal 
space, with no elevated mass and no calciﬁ cations, growing 
slowly along the retinal axis towards the anterior segment where 
late manifestations of the disease occur in the form of pseudo-
inﬂ ammatory complications. This is the diffuse inﬁ ltrating, or 
plaque-like form of retinoblastoma (Morgan 1971).
Endophytic retinoblastoma (Figures 2a and 2b) presents 
as one or more isolated or coalesced tumors of variable size, 
round or oval-shaped, yellowish-white (calciﬁ cations) or pink-
ish (vascularization) in color with its own, often turgescent and 
tortuous, vascular network. Endophytic retinoblastoma shows 
a marked tendency to invasion of the vitreous by seeding. 
Exophytic retinoblastoma (Figure 2c), developing outside the 
retina towards the choroid, causes a retinal detachment that 
masks to a greater or lesser degree the details of the underlying 
mass or masses. Seeding may occur in the subretinal ﬂ uid. Both 
endo- and exophytic forms are likely to develop calciﬁ cations, 
in the form of chalky white patches within the tumoral mass. 
Vitreous and subretinal seeding, along with calciﬁ cations, are 
the characteristics virtually pathognomonic of retinoblastoma 
(Figure 2d). The diffuse inﬁ ltrating form, however, presenting 
as a greyish retinal coating with no elevated mass and no calci-
ﬁ cations, may ﬁ nally manifest as a pseudo-hypopion (Morgan 
1971; Girard et al 1989). Finally, in probably 2%–5% of cases 
(Balmer and Munier 2002a), retinoblastoma may present in an 
inactive form indicative of spontaneous remission, called reti-
noma or, to use the histopathological term, retinocytoma. This is 
characterized by homogenous, more or less translucent greyish 
masses, calciﬁ cations, with pigment migration and proliferation 
bordering the tumor (Gallie et al 1982). In all respects, retinoma 
resembles a retinoblastoma sterilized by radiotherapy, without 
ever having undergone any treatment whatsoever.
Figure 2 (a) Small endophytic unifocal retinoblastoma. (b) Unifocal juxtapapillary lesion involving the macular, with xanthophile pigment visible superiorly. (c) Multifocal
retinoblastoma with foci visible beneath the detached retina and superfi cial vascular anomalies. (d) Multifocal retinoblastoma with calcifi cations and massive vitreous seeding.
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In the hereditary form of retinoblastoma there is also a risk 
of trilateral involvement, this the association of retinoblastoma, 
usually bilateral (90%) but not exclusively, with an intracranial 
neuroblastic tumor, commonly in the region of the pineal gland 
(pinealoblastoma), these cells being linked to the RB1 gene and of 
the same phylogenic origin as retinal tissues (De Potter et al 1994; 
Kivelä 1999). The vital prognosis for these cerebral tumors is very 
poor. Furthermore, children carrying the RB1 gene suffer life-long 
exposure to other non-ocular primary malignancies, in particular 
osteosarcoma of the orbit or elsewhere (Moll et al 1997, 2001; 
Abramson 1999; Abramson et al 2001). The risk is 1% per year 
of evolution and is particularly high in children having received 
radiotherapy before the age of one year (Abramson 1999).
Coats’ disease (primary retinal 
telangiectasia)
Coats’ disease, or primary (congenital) retinal telangiectasia, 
is a rare exudative retinopathy (Coats 1908; Balmer 2005; 
Shields et al 2001) (Figure 3). Unilateral in 90% of cases, the 
disease habitually affects young males (80%) between 5 and 
10 years old, although it can appear much earlier, before one 
year of age. It is non hereditary, probably congenital, with 
no known associated systemic diseases.
Clinical characteristics include three major features: retinal 
telangiectasia in the form of strings of fusiform dilatations of 
the retinal vessels, usually peripheral; massive yellowish exu-
dates within and underlying an edematous retina, sometimes 
giving a pseudo-tumoral appearance with a predilection for the 
macular area; exudative, sometimes total, retinal detachment 
(Figures 4b, 4c, and 4d). The exudates may be responsible 
for a luminous leukocoria (Figure 3a) but, in the presence of 
retinal detachment, this will take on a greyer hue.
The evolution of Coats’ disease is variable. It may 
stabilize, although often with loss of central vision due to 
macular lipid deposits, or deteriorate with total exudative 
retinal detachment (Figure 3d), iridis rubeosis, neovascular 
glaucoma, cataract, uveitis, phthisis bulbi and, ultimately, 
total and deﬁ nitive loss of vision.
Figure 3 (a) Coats’ disease: right leukocoria in a 2 year-old boy. (b) Coats’ disease: yellowish exudates covering the whole macular area. (c) Coats’ disease: extensive 
peripheral telangiectatic vessels and partial retinal detachment. (d) Coats’ disease: total bullous retinal detachment posterior to the clear lens and vascular telangiectasias.
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The primary lesion is most likely a localized, evolutive 
abnormality of the developing retinal vessels. The precise 
origin remains unknown, but Coats’ disease may be linked 
to a somatic mutation of the NDP gene (Norrie Disease 
Protein) leading to a deﬁ ciency of norrin in the developing 
retina (Black et al 1999).
Persistent hyperplastic primary 
vitreous (PHPV) or persistence
of the fetal vasculature (PFV)
Coats’ disease and persistence of Persistent Hyperplastic 
Primary Vitreous are the most common benign lesions 
to mimic retinoblastoma (Reese 1955; Goldberg 1997). 
PHPV is a congenital malformation caused by the arrest 
of normal regression of the embryonic vascular connective 
tissue (hyaloid artery, vasa hyaloidea propria, tunica vascu-
losa lentis), regression that normally occurs after 4 months 
gestation. Almost always unilateral, this condition often 
presents with moderate microphthalmia and other associated 
malformations such as failure of cleavage of the anterior 
segment or uveal coloboma. PHPV is non hereditary.
The most common signs and symptoms are leukocoria, 
this caused by retrolental ﬁ broplasia and/or cataract, microph-
thalmia and characteristic traction of the ciliary processes 
sometimes visible in the periphery of the dilated pupil.
Clinical manifestations of PHPV are varied and numer-
ous, affecting the anterior and/or posterior segments, rang-
ing from minimal isolated lesions to complex interactive 
secondary complications.
The natural course of the disease may result in early 
cataract and closed-angle glaucoma. In the long term, 
enucleation may be inevitable due to terminal glaucoma, 
intra-ocular hemorrhage, retinal detachment, uveitis or 
phthisis bulbi.
Retinopathy of prematurity (ROP)
Retinopathy of prematurity, known previously as retrolen-
tal ﬁ broplasia, results from the abnormal proliferation of 
retinal vessels, for the most part in premature infants with a 
birthweight less than 1250 gm or of under 32 weeks gesta-
tion. These children have usually received oxygen therapy, 
and the ﬁ rst signs of retinopathy appear between 35 and 45 
post-conceptional weeks. In the vast majority of cases spon-
taneous regression occurs over a period of 3 to 4 months. 
Only children of under 1000 gm birthweight are threatened 
with blindness.
The ﬁ rst and earliest clinical feature is a clear line of 
demarcation between the vascular and avascular retina 
(stage 1) (Anon 1987), indicating that angiogenesis is slow-
ing down or even arrested. Angiogenesis starts around the 
16th week of gestation and normally terminates at 36 weeks 
for the nasal retina, at term for the temporal retina. Capillary 
growth on the line of demarcation forms a prominent ridge 
(stage 2), a neoproliferation that may reach beyond the retina, 
inﬁ ltrating the internal limiting membrane and extending 
into the vitreous (stage 3). At this stage it forms a dense 
ﬁ brovascular membrane reaching from front to back of the 
vitreous body and may cause retraction of arborized vessels 
to form a falciform fold, papillary dysversion and macular 
ectopia. Unchecked, traction from the proliferation will cause 
initially a partial retinal detachment (stage 4), ultimately a 
total detachment (stage 5), ﬁ nally resulting in the cicatricial 
stage of retrolental ﬁ broplasia. Leukocoria may be present 
from stage 3 onwards.
The retinopathy may arrest spontaneously at any point 
of the natural course of the disease, the critical period being 
the stage when neovascularization invades the vitreous, the 
Figure 4 (a) Total retinal detachment in a 2 month-old boy. (b) Corresponding 
ultrasonography showing an intraocular mass with high refl ectivity (calcifi cations) 
and marked attenuation (shadowing) characteristic for retinoblastoma.
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retroequatorial zone and posterior pole. From this point, known 
as the “threshold disease”, the risk of blindness is 50% and 
cryotherapy is indicated (Early Treatment for Retinopathy of 
Prematurity Cooperative 2001, 2003; Palmer et al 2005).
Medulloepithelioma
Medulloepithelioma is a non hereditary tumor, usually unilat-
eral, deriving from the immature embryonic non-pigmented 
ciliary body (Andersen 1962; Broughton and Zimmerman 
1978) or, more rarely, from the optic nerve or retina. First 
manifestations usually occur in early childhood, occasionally 
in the adult, with leukocoria, poor vision and typically a vas-
cularized iris mass, this greyish or salmon-colored, in some 
cases pigmented. The tumor may be polycystic and cystic 
fragments may be found liberated into the aqueous humor 
or vitreous body. Tumor growth is slow, developing in the 
surrounding structures of the anterior segment or towards the 
optic nerve. It is difﬁ cult to assess the benign or malignant 
nature of the tumor, even on histopathological examination 
(Broughton and Zimmerman 1978).
Optic nerve glioma
Optic nerve glioma is the most frequent intrinsic tumor of the 
anterior portion of the optic nerve (65%), followed by menin-
gioma (35%, Dutton, 1994). Preschool or school-age children 
are most often affected and the ﬁ rst manifestations are usually 
exophthalmia and loss of vision (Dutton, 1994, Hamelin et al 
2000). The tumor is associated with neuroﬁ bromatosis in over 
30% of cases. A true neoplasm, optic nerve glioma presents 
phases of rapid growth followed by stagnation, sometimes 
even spontaneous regression (Parsa et al 2001). The tumor 
may remain dormant for long periods of time then suddenly 
resume growth in a wholly unpredictable manner. Papillary 
and intraocular involvement is possible but very rare.
The mortality rate is low (5%) as long as the tumor is 
restricted to the optic nerve. However, invasion of surround-
ing tissues may lead to involvement of the chiasma and 
inﬁ ltration of adjacent cerebral structures. Involvement of 
the hypothalamus and third ventricule considerably increases 
the mortality rate, this reaching 50% after 15 years follow-up 
(Dutton 1994).
In the adult, optic nerve glioma is malignant and invari-
ably fatal due to involvement of the chiasma and cerebral 
structures.
Methods of diagnosis
In difﬁ cult cases, where fundus examination alone does not 
enable diagnosis to be made with certainty (around 10% of 
cases), ultrasonography is the next method of choice, this 
being an inexpensive, inoffensive and highly speciﬁ c means 
of detecting the calciﬁ cations distinctive of retinoblastoma 
(Figures 4a and 4b).
OCT (optical coherence tomography) is used more 
and more frequently to evaluate macular tumors or 
simulating lesions. Non invasive and well tolerated, it 
provides invaluable information on the presence of ﬁ bro-
sis, edema or subretinal ﬂ uid in the foveal area (Shields 
et al 2004).
A CT scan is useful in detecting calciﬁ cations that may 
have escaped ultrasonography but does involve X-rays and 
is thus potentially dangerous with cumulative examinations 
(Apushkin et al 2005).
Magnetic resonance imaging (MRI) is ideal for detecting 
any budding asymptomatic tumor of the pineal gland or optic 
chiasma in hereditary bilateral multifocal cases (trilateral 
retinoblastoma). It also enables differentiation between solid 
tumors (over 2 mm diameter) and lesions surrounded with 
subretinal ﬂ uid, as is the case with advanced Coats’ disease 
or PFV (Apushkin et al 2005).
The role of the primary care 
physician
Whether the family doctor or pediatrician, the primary care 
physician is usually the ﬁ rst to be confronted with the prob-
lem and thus plays an essential role, as the evolution and 
ultimate outcome of the disease will depend on the speed of 
reaction at this initial stage.
Any report of a white pupil, whatever the context, should 
be taken seriously and, until proved otherwise, considered to 
be at best the result of a benign malformation, at worst the 
ﬁ rst sign of cancer of the retina, retinoblastoma.
A full family anamnesis is essential, with particular 
attention to any history of enucleation in infancy. The age of 
the child should be taken into account and a full description 
of the anomaly noted. An assessment of the child’s vision 
(ﬁ xation and ability to follow objects), iris color and eye 
position (strabismus) will be recorded. Most importantly, 
any leukocoria must be sought out with the use of a pen torch 
under subdued lighting (McLaughlin and Levin 2006). All 
positions of gaze should be elicited, ﬁ rst of all in miosis then 
repeated with the pupil fully dilated, taking advantage of 
mydriasis to detect any anomaly of the macular or papillary 
region on ophthalmoscopy.
Whether the leukocoria or any retinal lesion be conﬁ rmed 
at this stage or not, there should be no delay in referring 
the child to a specialist. Depending on the outcome of this 
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second examination, further investigations at a reference 
center may be required.
Conclusions
Many ocular conditions in childhood may mimic retinoblas-
toma, either by similar ﬁ rst signs, leukocoria in particular, 
similar clinical features, or by comparable evolutive com-
plications. Correct diagnosis without delay is imperative 
as retinoblastoma puts a child’s vision, and indeed life, 
in danger (Goddard et al 1999; Wallach et al 2006). Early 
treatment is and will remain the best possible treatment for 
this highly malignant tumor. Keeping in mind a possible 
diagnosis of retinoblastoma is the ﬁ rst major step to a full 
recovery.
Early diagnosis concerns everybody in contact with the 
child, the parents, family/friends, nurses, the family doc-
tor, often ﬁ rst to be confronted with the initial signs, also 
specialists and reference centers. Leukocoria, or any other 
unexplained ocular sign in an infant should always, until 
proved otherwise, invoke the possibility of a malignant 
tumor and put in motion all the necessary means for prompt 
diagnosis.
References
Abramson DH. 1999. Second nonocular cancers in retinoblastoma: 
a uniﬁ ed hypothesis. The Franceschetti Lecture. Ophthalmic Genet, 
20:193–204.
Abramson DH, Beaverson K, Sangani P, et al. 2003. Screening for reti-
noblastoma: presenting signs as prognosticators of patient and ocular 
survival. Pediatrics, 112:1248–55.
Abramson DH, Frank CM, Susman M, et al. 1998. Presenting signs of 
retinoblastoma. J Pediatr, 132:505–8.
Abramson DH, Melson MR, Dunkel IJ, et al. 2001. Third (fourth and ﬁ fth) 
nonocular tumors in survivors of retinoblastoma. Ophthalmology, 
108:1868–76.
Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, et al. 2006. Retinoblas-
toma. Orphanet J Rare Dis, 1:31.
Andersen SR. 1962. Medulloepithelioma of the retina. Int Ophthalmol 
Clin, 2:483–506.
[Anon]. 1987. An international classiﬁ cation of retinopathy of prematurity. 
II. The classiﬁ cation of retinal detachment. The International Committee 
for the Classiﬁ cation of the Late Stages of Retinopathy of Prematurity. 
Arch Ophthalmol, 105:906–12.
Apushkin MA, Shapiro MJ, Mafee MF. 2005. Retinoblastoma and 
simulating lesions: role of imaging. Neuroimaging Clin N Am, 
15:49–67.
Augsburger JJ, Oehlschlager U, Manzitti JE. 1995. Multinational clinical 
and pathologic registry of retinoblastoma. Retinoblastoma International 
Collaborative Study report 2. Graefes Arch Clin Exp Ophthalmol, 
233:469–75.
Balmer A, Gailloud C, Munier F, et al. 1994. [Unusual presentation of 
retinoblastoma]. Klin Monatsbl Augenheilkd, 204.
Balmer A, Gailloud C, Uffer S, et al. 1988. [Retinoblastoma and pseudoreti-
noblastoma: diagnostic study]. Klin Monatsbl Augenheilkd, 192.
Balmer A, Munier F. 2002a. Rétinoblastome: diagnostic. In: Zografos L 
ed. Tumeurs intraoculaires. Paris: Société Française d’Ophtalmologie 
et Masson. p 485–533.
Balmer A, Munier F. 2002b. Rétinoblastome: Epidémiologie. In: Zografos L 
ed. Tumeurs intraoculaires. Paris: Société Française d’Ophtalmologie 
et Masson. p 481–5.
Balmer A, Zografos L, Uffer S, et al. 2005. Maladie de Coats et télangiec-
tasies primaires et secondaires. In: Médico-Chirurgicale E ed. Ophtal-
mologie. Paris: Elsevier SAS. p 21–240–E–30.
Binder PS. 1974. Unusual manifestations of retinoblastoma. Am J Oph-
thalmol, 77:674–9.
Black GC, Perveen R, Bonshek R, et al. 1999. Coats’ disease of the retina
(unilateral retinal telangiectasis) caused by somatic mutation in the NDP 
gene: a role for norrin in retinal angiogenesis. Hum Mol Genet, 8:2031–5.
Bornfeld N, Schuler A, Boloni R, et al. 2006. [Retinoblastoma]. Ophthal-
mologe, 103:59–76; quiz 77–8.
Broughton WL, Zimmerman LE. 1978. A clinicopathologic study of 
56 cases of intraocular medulloepitheliomas. Am J Ophthalmol, 
85:407–18.
Brückner R. 1962. Exakte Strabismusdiagnostik bei 1/2–3 jährigen Kindern 
mit einem einfachen Verfahren, dem “Durchleuchtungstest”. Ophthal-
mologica, 149:184–98.
Coats G. 1908. Forms of retinal diseases with massive exudation. Roy Lond 
Ophthalmol Hosp Rep, 17:440–525.
Cryotherapy for Retinopathy of Prematurity Cooperative Group. 2001. 
Multicenter Trial of Cryotherapy for Retinopathy of Prematu-
rity: ophthalmological outcomes at 10 years. Arch Ophthalmol, 
119:1110–8.
de Leon JM, Walton DS, Latina MA, et al. 2005. Glaucoma in retinobla-
stoma. Semin Ophthalmol, 20:217–22.
De Potter P, Shields JA, Shields CL. 1994. Clinical variations of trilateral 
retinoblastoma: a report of 13 cases. J Pediatr Ophthalmol Strabismus, 
31:26–31.
DerKinderen DJ, Koten JW, Tan KE, et al. 1990. Parental age in sporadic 
hereditary retinoblastoma. Am J Ophthalmol, 110:605–9.
Dollfus M-A, Auvert B. 1953. Le gliome de la rétine (rétinoblastome) et 
les pseudogliomes. Etude clinique, génétique et thérapeutique. Paris: 
Société française d’Ophtalmologie.
Dutton JJ. 1994. Gliomas of the anterior visual pathway. Surv Ophthalmol, 
38:427–52.
Early Treatment For Retinopathy Of Prematurity Cooperative. 2003. Revised 
indications for the treatment of retinopathy of prematurity: results of the 
early treatment for retinopathy of prematurity randomized trial. Arch 
Ophthalmol, 121:1684–94.
Gallie BL, Ellsworth RM, Abramson DH, et al. 1982. Retinoma: spon-
taneous regression of retinoblastoma or benign manifestation of the 
mutation?. Br J Cancer, 45:513–21.
Girard B, Le Hoang P, D’Hermies F, et al. 1989. Le rétinoblastoma inﬁ ltrant 
diffus. J Fr Ophtalmol, 12:369–81.
Goddard AG, Kingston JE, Hungerford JL. 1999. Delay in diagnosis of 
retinoblastoma: risk factors and treatment outcome. Br J Ophthalmol, 
83:1320–3.
Goldberg MF. 1997. Persistent fetal vasculature (PFV): an integrated inter-
pretation of signs and symptoms associated with persistent hyperplastic 
primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am 
J Ophthalmol, 124:587–626.
Halperin EC. 2000. Neonatal neoplasms. Int J Radiat Oncol Biol Phys, 
47:171–8.
Hamelin N, Becquet F, Dureau P, et al. 2000. Particularités cliniques des 
gliomes du chiasma. Etude rétrospective sur une série de 18 patients. 
J Fr Ophtalmol, 23:694–8.
Howard GM, Ellsworth RM. 1965a. Differential diagnosis of retinoblastoma. 
A statistical survey of 500 children. I. Relative frequency of the lesions 
which simulate retinoblastoma. Am J Ophthalmol, 60:610–8.
Howard GM, Ellsworth RM. 1965b. Differential diagnosis of retinoblas-
toma. A statistical survey of 500 children. II. Factors relating to the 
diagnosis of retinoblastoma. Am J Ophthalmol, 60:618–21.
Kivelä T. 1999. Trilateral retinoblastoma: a meta-analysis of hereditary reti-
noblastoma associated with primary ectopic intracranial retinoblastoma. 
J Clin Oncol, 17:1829–37.
Clinical Ophthalmology 2007:1(4) 439
Differential diagnosis of leukocoria and strabismus
Maat-Kievit JA, Oepkes D, Hartwig NG, et al. 1993. A large retinoblastoma 
detected in a fetus at 21 weeks of gestation. Prenat Diagn, 13:377–84.
Mahoney MC, Burnett WS, Majerovics A, et al. 1990. The epidemiology of 
ophthalmic malignancies in New York State. Ophthalmology, 97:1143–7.
Matsunaga E, Minoda K, Sasaki MS. 1990. Parental age and seasonal 
variation in the births of children with sporadic retinoblastoma: a muta-
tion-epidemiologic study. Hum Genet, 84:155–8.
McLaughlin C, Levin AV. 2006. The red reﬂ ex. Pediatr Emerg Care, 
22:137–40.
Miller RW. 1969. Fifty-two forms of childhood cancer: United States mor-
tality experience, 1960-1966. J Pediatr, 75:685–9.
Moll AC, Imhof SM, Bouter LM, et al. 1997. Second primary tumors in 
patients with retinoblastoma. A review of the literature. Ophthalmic 
Genet, 18:27–34.
Moll AC, Imhof SM, Schouten-Van Meeteren AY, et al. 2001. Second 
primary tumors in hereditary retinoblastoma: a register-based study, 
1945–1997: is there an age effect on radiation-related risk? Ophthal-
mology, 108:1109–14.
Morgan G. 1971. Diffuse inﬁ ltrating retinoblastoma. Br J Ophthalmol, 
55:600.
Munier F, Balmer A. 2002. Rétinoblastome: génétique. In Zografos L (ed). 
Tumeurs intraoculaires. Paris: Société Française d’Ophtalmologie et 
Masson. p 467–80.
Palmer EA, Hardy RJ, Dobson V, et al. 2005. 15-year outcomes following 
threshold retinopathy of prematurity: ﬁ nal results from the multicenter 
trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol, 
123:311–8.
Parsa CF, Hoyt CS, Lesser RL, et al. 2001. Spontaneous regression of 
optic gliomas: thirteen cases documented by serial neuroimaging. Arch 
Ophthalmol, 119:516–29.
Reese AB. 1955. Persistent hyperplastic primary vitreous. The Jackson 
Memorial Lecture. Am J Ophthalmol, 40:317–31.
Scat Y, Liotet S, Carre F. 1996. Etude épidémiologique de 1705 tumeurs 
malignes de l’oeil et de ses annexes. J Fr Ophtalmol, 19:83–8.
Shields CL, Mashayekhi A, Luo CK, et al. 2004. Optical coherence tomog-
raphy in children: analysis of 44 eyes with intraocular tumors and 
simulating conditions. J Pediatr Ophthalmol Strabismus, 41:338–44.
Shields JA, Parsons HM, Shields CL, et al. 1991. Lesions simulating reti-
noblastoma. J Pediatr Ophthalmol Strabismus, 28:338–40.
Shields JA, Shields CL, Honavar SG, et al. 2001. Clinical variations and 
complications of Coats disease in 150 cases: the 2000 Sanford Gifford 
Memorial Lecture. Am J Ophthalmol, 131:561–71.
Shields JA, Shields CL, Parsons HM. 1991. Differential diagnosis of reti-
noblastoma. Retina, 11:232–43.
Wallach M, Balmer A, Munier F, et al. 2006. Shorter time to diagnosis and 
improved stage at presentation in Swiss patients with retinoblastoma 
treated from 1963 to 2004. Pediatrics, 118:e1493–8.
Yanoff M, Zimmerman LE, Davis RL. 1971. Massive gliosis of the retina. 
Int Ophthalmol Clin, 11:211–29.

